A new FDA approval gives some men with advanced prostate cancer another treatment option.

On July 31, 2026, the U.S. Food and Drug Administration (FDA) approved Pluvicto for some men whose prostate cancer has spread but still responds to hormone therapy.

Radioligand therapy (RLT) is one of the most exciting advances in precision cancer treatment. By combining a targeting molecule with a small amount of radiation, RLT delivers treatment directly to cancer cells while minimizing damage to surrounding healthy tissue.

Cribriform prostate cancer is a word pathologists use to describe how prostate cancer cells look under the microscope. The cells form large, sieve-like groups with tiny holes inside them. It is not a separate disease…

These annual honors spotlight individuals who have made a lasting impact through research, advocacy, and patient support….

Former president Joseph Biden has been diagnosed with advanced prostate cancer. We at the PCRI are saddened by this news, as this kind of a diagnosis is a radically life altering event that sends ripples through the lives of those diagnosed, and the community that surrounds them. Our thoughts and prayers are with the Biden family as they battle this harsh diagnosis.

Verne Varona has become an international renowned keynote speaker with a captivating style that uses humor, insight, and practical science to improve and enrich the lives of many. He studied traditional Chinese medicine and nutrition at the East West Foundation of Boston, Massachusetts.

On May 17, Howard Wolinski hosted an excellent interview with Dr. Jonathan Epstein for The Active Surveillor webinar series. Available now on The Surveillor’s YouTube channel, Dr. Epstein discusses key topics including which patients qualify for Active Surveillance, the significance of cribriform patterns, and the role of AI in prostate cancer management. A must-watch for anyone interested in the latest in prostate cancer care.

This event is a welcoming opportunity for patients to learn more about active surveillance, connect with others on a similar journey, and build a supportive community. Whether you're newly diagnosed or have been on surveillance for a while, you are warmly invited to be part of this conversation.